HMGB1 (High mobility group protein B1) promotes HCC progression by impairing the function of CD8+ effector T cells by triggering TIM-1+ B cell expansion, inducing TNF-α and IFN-γ factor secretion, and inhibiting CD8+ T cell proliferation (28). Here, HMGB1 is linked to hepatocellular carcinoma.